BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35860569)

  • 1. Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer.
    Tang L; Li W; Xu H; Zheng X; Qiu S; He W; Wei Q; Ai J; Yang L; Liu J
    Front Oncol; 2022; 12():876531. PubMed ID: 35860569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma.
    Yang L; Guo G; Yu X; Wen Y; Lin Y; Zhang R; Zhao D; Huang Z; Wang G; Yan Y; Zhang X; Chen D; Xing W; Wang W; Zeng W; Zhang L
    Front Oncol; 2022; 12():780631. PubMed ID: 35372012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma.
    Duan BT; Zhao XK; Cui YY; Liu DZ; Wang L; Zhou L; Zhang XY
    World J Gastrointest Surg; 2024 Mar; 16(3):842-859. PubMed ID: 38577085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.
    Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD
    Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma.
    Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z
    Front Genet; 2022; 13():874673. PubMed ID: 35547247
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma.
    Zhu J; Huang Q; Liu S; Peng X; Xue J; Feng T; Huang W; Chen Z; Lai K; Ji Y; Wang M; Yuan R
    Front Immunol; 2022; 13():856186. PubMed ID: 35479067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
    Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
    Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer.
    Zhu X; Yu R; Peng Y; Miao Y; Jiang K; Li Q
    Front Genet; 2022; 13():990661. PubMed ID: 36118868
    [No Abstract]   [Full Text] [Related]  

  • 10. Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer.
    Liang Y; Ye F; Cheng Z; Ou Y; Zou L; Hu Y; Hu J; Jiang H
    Cancer Cell Int; 2021 Sep; 21(1):476. PubMed ID: 34496843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis.
    Wu J; Ren X; Wang N; Zhou R; Chen M; Cai Y; Lin S; Zhang H; Xie X; Dang C; Zhang S; Zhou Z
    Front Genet; 2021; 12():779554. PubMed ID: 34880908
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.
    Wu H; Zhang ZY; Zhang Z; Xiao XY; Gao SL; Lu C; Zuo L; Zhang LF
    Bioengineered; 2021 Dec; 12(1):1725-1738. PubMed ID: 33955803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
    Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
    Front Genet; 2021; 12():706661. PubMed ID: 34712264
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer.
    Liu J; Cui G; Ye J; Wang Y; Wang C; Bai J
    Front Cell Dev Biol; 2022; 10():753957. PubMed ID: 35433686
    [No Abstract]   [Full Text] [Related]  

  • 15. A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.
    Ren L; Yang X; Wang W; Lin H; Huang G; Liu Z; Pan J; Mao X
    Front Genet; 2023; 14():1096783. PubMed ID: 36911392
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
    Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
    Front Immunol; 2022; 13():970588. PubMed ID: 36148233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver Cancer.
    Guo C; Zhou J; Ma B; Wang R; Ge Y; Wang Z; Ji B; Wang W; Zhang J; Wang Z
    Front Surg; 2021; 8():724792. PubMed ID: 34504866
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma.
    Peng B; Li H; Na R; Lu T; Li Y; Zhao J; Zhang H; Zhang L
    Front Cell Dev Biol; 2021; 9():706454. PubMed ID: 34336859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of genomic instability-associated long non-coding RNA signature: A prognostic risk model of clear cell renal cell carcinoma.
    Jiang D; Wu T; Shi N; Shan Y; Wang J; Jiang H; Wu Y; Wang M; Li J; Liu H; Chen M
    Front Oncol; 2022; 12():1019011. PubMed ID: 36387102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.
    Bao S; Zhao H; Yuan J; Fan D; Zhang Z; Su J; Zhou M
    Brief Bioinform; 2020 Sep; 21(5):1742-1755. PubMed ID: 31665214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.